Abstract
The aim of this study was to determine in young, healthy men the relative contribution of pharmacodynamic factors inherent between two groups known to respond differently to hypertensive therapy. Black (n = 10) and white (n = 10) men received an isoproterenol sensitivity test before and after propranolol (0.1 mg/kg, then 50 µg/min). There were greater increases (twofold) in systolic BP following the 1.0- and 1.5-µg isoproterenol dose (P < 0.05) in the black group. During propranolol there were no differences in free (1)-propranolol concentrations between the groups; however, propranolol decreased resting heart rate in the white group more than in the black group (P < 0.05). Cardiac index decreased less in the black group compared to the white group (P < 0.05). Following the second isoproterenol challenge, there again were greater increases in systolic BP in the black group at both the 10- and the 20-µg isoproterenol dose (P < 0.05). Our study has highlighted the importance of cross-racial studies in evaluating drug effects.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
C. E. Gomez-Sanchez and O. B. Holland. Urinary tetrahydroaldosterone and aldosterone-18-glucouronide excretion in white and black normal subjects and hypertensive patients. J. Clin. Endocrinol. Metab. 52:214–219 (1981).
J. H. Pratt, J. J. Jerrlyn, J. Z. Miller, M. A. Wagner, and N. S. Fineberg. Racial differences in aldosterone excretion and plasma aldosterone concentrations in children. N. Engl. J. Med. 321:1152–1157 (1989).
H. H. Zhou, R. P. Koshakji, D. J. Silberstein, G. R. Wilkinson, and A. J. J. Wood. Racial differences in drug response: altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American Whites. N. Engl. J. Med 320:565–570 (1989).
D. R. Rutledge, L. Cardozo and J. D. Steinberg. Racial differences in drug response: Isoproterenol effects on heart rate in healthy males. Pharm. Res. 6:182–185 (1989) [See erratum 6:528 (1989).]
D. R. Rutledge, J. Steinberg, and L. Cardozo. Racial differences in drug response: Isoproterenol effects on heart rate following intravenous metoprolol. Clin. Pharmacol. Ther. 45:380–386 (1989).
K. K. Chen and E. J. Poth. Racial differences as illustrated by the mydriatic actions of cocaine, euphthalamine and ephedrine. J. Pharmacol. Exp. Ther. 36:429–445 (1929).
T. G. Scott. The eye of the West African Negro. Br. J. Ophthalmol. 29:12 (1945).
Veterans Administration Cooperative Study Group on Antihypertensive Agents. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. JAMA 248:1996–2003 (1982).
Veterans Administration Cooperative Study Group on Antihypertensive Agents. Efficacy of nadolol alone and combined with bendroflumethiazide and hydralazine for systemic hypertension. Am. J. Cardiol. 52:1230–1237 (1983).
Y. K. Seedat. Trial of atenolol and chlorthalidone for hypertension in black South Africans. Br. Med. J. 281:1241–1243 (1980).
M. Moser and J. Lunn. Comparative effects of pindolol and hydrochlorothiazide in black hypertensive patients. Angiology 32:561–566 (1981).
C. R. Cleveland, R. E. Rangno, and D. G. Shand. A standard isoproterenol sensitivity test. Arch. Intern. Med. 130:45–51 (1972).
D. R. Rutledge and C. Garrick. Rapid high-performance liquid chromatographic method for the measurement of the enantiomers of metoprolol in serum using a chiral stationary phase. J. Chromatgr. 497:181–190 (1989).
J. Huang. Errors in estimating the unbound fraction of drugs due to the volume shift in equilibrium dialysis. J. Pharm. Sci. 72:1368–1369 (1983).
D. G. McDevitt, M. Frisk-Holmberg, J. W. Hollifield, and D. G. Shand. Plasma binding and the affinity of propranolol for a beta receptor in man. Clin. Pharmacol. Ther. 20:152–157 (1976).
C. Von Bahr, J. Hermansson, and K. Tawara. Plasma levels of (+) and (−)-propranolol and 4-hydroxypropranolol after administration of racemic (±)-propranolol in man. Br. J. Clin. Pharmacol. 14:79–82 (1982).
C. P. Venter and P. H. Joubert. Ethnic differences in response to beta-1 adrenoceptor blockade by propranolol. J. Cardiovasc. Pharmacol. 6:361–364 (1984).
H. H. Vincent, A. J. Man In't Veld, F. Boomsma, G. J. Wenting, and M. A. D. H. Schalekamp. Elevated plasma noradrenaline in response to beta adrenoceptor stimulation in man. Br. J. Clin. Pharmacol. 13:717–721 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rutledge, D.R., Wallace, A., Steinberg, J.D. et al. Racial Differences in Drug Response: Isoproterenol Effects Before and After Propranolol. Pharm Res 8, 754–757 (1991). https://doi.org/10.1023/A:1015806202180
Issue Date:
DOI: https://doi.org/10.1023/A:1015806202180